Meptazinol
((m-3-ethyl-l-methylhexahydro-l-Hazapine-3-ylphenol) hydrochloride, Wyeth Laboratories) is an opioid antagonist drug with analgesic properties. Paymaster (1976 Paymaster ( , 1977 has shown that it produces significant pain relief in doses of 60-150 mg per 70 kg i.m. in patients recovering from abdominal surgery and, orally, meptazinol 400 mg was significantly better than placebo in relieving pain after operation in patients who had undergone total abdominal hysterectomy operations (Hedges et al., 1977) . The i.v. administration of meptazinol was effective in relieving the pain of acute renal colic (Oosterlinck and de Sy, 1975) .
The present study was carried out to evaluate the efficacy of three doses of meptazinol administered i.m., compared with pethidine, in relieving pain following surgery.
METHODS
Three groups, each of 24 female patients aged 27-64 yr who had undergone total abdominal hysterectomy, were studied. In group 1, meptazinol 60 mg was compared with pethidine 100 mg; in group 2, meptazinol 75 mg was compared with pethidine 100 mg and, in group 3, meptazinol 100 mg was compared with pethidine 100 mg. The informed consent of the patients to participate in the trial was obtained; all tests were carried out on the first day after operation. Patients were specifically excluded from the trial if they suffered from cardiac, pulmonary, renal or hepatic disease. The drugs were administered i.m. to the patients in a cross-over design under double-blind conditions in random order, according to an individual numerical code.
The analgesic efficacy of the two treatments was assessed by: (a) interviewing the patients 1 h after they had received each injection; (b) noting the times that the injections were administered and the time at the end of the trial when the next analgesic, either pethidine or papaveretum, was given; (c) recording the side-effects of either treatment noted by the patient; (d) the patients were asked by means of a multichoice questionnaire (1) to rate their initial level of pain before the injection as "slight", "quite severe" or "as severe as I have ever felt it"; (2) to rate their pain relief 1 h after the injection as: not changed at all = 0, slight relief = 1, moderate relief = 2, almost complete relief = 3, complete relief = 4; and (3) to select their preference, if any, for either treatment. From this, it was possible to obtain an investigatorpreference for treatment by one of us (A. H.), based solely on the degree of pain relief, and a patient preference for treatment.
Statistical analysis
The patient and investigator preferences and the pain relief ratings were analysed using McNemar's test. Wilcoxon's matched pairs signed-ranks test was used to assess the significance of the difference of 
RESULTS
The patient and observer preferences for treatment in the three groups are shown in table I. Patient preference for pethidine 100 mg compared with meptazinol 60 mg was significant (McNemar's test, X 2 =7.6, P<0.01). However, when the dose of meptazinol was increased to 75 mg or 100 mg, there was no significant difference between meptazinol and pethidine 100 mg on patient or observer preference.
In table II, the pain relief scores are subdivided according to the initial pain experienced by the patients. Pethidine was not significantly better than any dose of meptazinol in relieving pain.
Although more patients had better pain relief scores after pethidine 100 mg than any dose of In all three groups after pethidine or meptazinol administration there was no significant difference between the time until the next analgesic dose (table IV) . The side-effects which were noted by the patients are listed in table V. The results of the present study confirm those of other workers (Paymaster, 1976 (Paymaster, , 1977 ) that meptazinol is an effective analgesic in pain after operation. Paymaster (1977) has shown that i.m. meptazinol 100 mg was equianalgesic with pethidine 100 mg in relieving pain following abdominal and orthopaedic surgery. Meptazinol 100 mg produced less sedation and had less adverse effects on lung function tests than pethidine 100 mg (Paymaster, 1977) . The negligible depressant action of meptazinol on respiration was confirmed by Jordan and others (1979) , who showed that meptazinol 100 mg per 70 kg, unlike morphine 20 mg per 70 kg or pentazocine 60 mg per 70 kg, had little effect on the slope and intercept of the ventilatory response to hypercapnia. The main side-effects associated with meptazinol in this study were nausea and dizziness, which have also been reported by other workers (Paymaster, 1977; Jordan et al., 1979) . However, in all these studies, the frequency of side-effects was not greater in the meptazinol group than in the pethidine group. If the finding in rats (Goode and White, 1971 ) and drug-addicted monkeys (Swain, Villancal and Seevers 1973) of the low-dependence factor for meptazinol is confirmed in man, meptazinol, as a potent analgesic with minimal respiratory depressant action, would be particularly useful when pain relief is required in patients with poor pulmonary function, in women during labour and during the period immediately after operation.
